HAS Corporate Logo HAS Corporate Logo
  • Home
  • About
    • Partnerships
  • Services
    • Market Access Analytics and Insight
    • NICE HTA Strategy and Submission
    • Health Economics and Outcomes Research (HEOR)
    • Strategy Development
    • Reimbursement Strategy and Support
    • NHS Drug Tariff Submission Support
    • Private healthcare
    • Value Proposition Development for MedTech
    • Primary Care Market Insights
    • Stakeholder Engagement for Health Technologies
    • Sustainability and NET Zero for MedTech
    • Evidence Generation and Management
    • Dashboard Tools for Market Access
    • MedTech Sales Team Empowerment
    • NHS MedTech Business Case Formulation
  • Blog
  • Resources
Contact Us
  • Sun images
  • Vector Images
HAS Corporate Logo
  • Home
  • About
    • Partnerships
  • Services
    • Market Access Analytics and Insight
    • NICE HTA Strategy and Submission
    • Health Economics and Outcomes Research (HEOR)
    • Strategy Development
    • Reimbursement Strategy and Support
    • NHS Drug Tariff Submission Support
    • Private healthcare
    • Value Proposition Development for MedTech
    • Primary Care Market Insights
    • Stakeholder Engagement for Health Technologies
    • Sustainability and NET Zero for MedTech
    • Evidence Generation and Management
    • Dashboard Tools for Market Access
    • MedTech Sales Team Empowerment
    • NHS MedTech Business Case Formulation
  • Blog
  • Resources

Where the Pressure Sits

Related services

Let's talk

  • Richard Tuson
  • /
  • 15 Aug 2025

NHS waiting list pressures are not spread evenly – and some specialties are feeling it far more than others.

Since 2019, the biggest growth in waiting lists has been in:

 • Orthopaedics

 • ENT

 • Gynaecology

 • Dermatology

These are high-volume, high-impact specialties driving much of the national backlog. To make progress, the NHS needs solutions that improve productivity and free capacity – particularly where delays are greatest.

Targeted MedTech adoption offers one of the fastest, most scalable ways to deliver that change.

At Health Analytical Solutions Ltd, we’ve worked with over 150 technologies – including 30 with NICE approval – helping innovators navigate NHS coding, reimbursement, and adoption pathways. If you have a technology that could help the NHS deliver more, faster, we can help you get it in use.

Our Latest Insights.

 
  • Richard Tuson

June 2025 NHS Diagnostic Waiting Lists

 
  • Richard Tuson

Community Diagnostic Centres: Extending Access and Reducing Delays

 
  • Richard Tuson

Where the Pressure Sits

 
  • Richard Tuson

Waiting List Rises Again

Health Analytical Solutions

  • About
  • Services
  • Blog
  • Resources
  • Contact Us

Services

  • Market Access Analytics and Insight
  • NICE HTA Strategy and Submission
  • Health Economics and Outcomes Research (HEOR)
  • Strategy Development
  • Reimbursement Strategy and Support
  • NHS Drug Tariff Submission Support
  • Private healthcare
  • Value Proposition Development for MedTech
  • Primary Care Market Insights
  • Stakeholder Engagement for Health Technologies
  • Sustainability and NET Zero for MedTech
  • Evidence Generation and Management
  • Dashboard Tools for Market Access
  • MedTech Sales Team Empowerment
  • NHS MedTech Business Case Formulation

Stay Up To Date

  • Privacy Policy
  • Cookie Policy
  • Terms of Use
  • Contact Us

© Health Analytical Solutions 2025